Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11.18 USD | +0.40% | -3.62% | -0.45% |
04-05 | Arbutus Biopharma Obtains Favorable Court Order in Moderna Patent Lawsuit | MT |
04-04 | Moderna Suffers Setback in Lawsuit by Arbutus | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.45% | 8.97B | |
+30.02% | 684B | |
+30.34% | 568B | |
-3.82% | 361B | |
+18.11% | 329B | |
+4.04% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.18% | 166B |
- Stock Market
- Equities
- ROIV Stock
- News Roivant Sciences Ltd.
- Transcript : Roivant Sciences Ltd., Q3 2024 Earnings Call, Feb 13, 2024